County-level geographical septile distribution for the first 12 statistically significant factors with at least one statistically significant coefficient ranked by decreasing ΔIC. by Yanan Long (11784717)

Significant condition. by Junxia Zhou (14381598)

Subjects:

Group-based descriptive statistics and effect sizes. by Murat Tutar (22250461)

Results of significance for regression factors. by Junxia Zhou (14381598)

Subjects:

Particle size distribution of GO-GA NPs. by Huda H. Elbehery (22492996)

Subjects:

Individual tumour size developments. by Philine Steinbach (17847521)

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”

Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy. by Molly B. El Alam (10231830)

Sample size estimation based on preliminary date. by Jacquelyn Y. Taylor (6386456)

Effective population size (Ne) over generations based on linkage disequilibrium calculations. by Akansha Singh (669369)

Subjects:

Particle size distribution, PDI, and zeta potential of GO-GA NPs. by Huda H. Elbehery (22492996)

Subjects:

rt-PA-induced lysis of different clot sizes. by Jan Víteček (11434774)

The variables that significantly predicted litter clump weight in shelter cats. by Allison Andrukonis (11846404)

Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease. by Emir Matpan (21655811)

“…Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease.…”

Vibriocidal activities were significantly decreased by depletion of IgM in serum. by Jae Seung Yang (701319)

Image_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.TIF by Britta Hanssen (4898155)

“…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”

Table_2_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”

Table_3_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”

Table_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”

The 11 surgery categories and corresponding sample sizes, 2002–2015. by Ning Ning (464160)